Tags

Type your tag names separated by a space and hit enter

Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women.
Emerg Infect Dis. 2014 Feb; 20(2)EI

Abstract

In August 2012, the Centers for Disease Control and Prevention, in partnership with the Association of Maternal and Child Health Programs, convened a meeting of national subject matter experts to review key clinical elements of anthrax prevention and treatment for pregnant, postpartum, and lactating (P/PP/L) women. National experts in infectious disease, obstetrics, maternal fetal medicine, neonatology, pediatrics, and pharmacy attended the meeting, as did representatives from professional organizations and national, federal, state, and local agencies. The meeting addressed general principles of prevention and treatment for P/PP/L women, vaccines, antimicrobial prophylaxis and treatment, clinical considerations and critical care issues, antitoxin, delivery concerns, infection control measures, and communication. The purpose of this meeting summary is to provide updated clinical information to health care providers and public health professionals caring for P/PP/L women in the setting of a bioterrorist event involving anthrax.

Links

PMC Free PDF

Authors

Meaney-Delman D
No affiliation info available
Zotti ME
No affiliation info available
Creanga AA
No affiliation info available
Misegades LK
No affiliation info available
Wako E
No affiliation info available
Treadwell TA
No affiliation info available
Messonnier NE
No affiliation info available
Jamieson DJ
No affiliation info available
Workgroup on Anthrax in Pregnant and Postpartum Women
No affiliation info available

MeSH

AdultAnthraxAnthrax VaccinesAnti-Bacterial AgentsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntitoxinsBacillus anthracisBioterrorismCenters for Disease Control and Prevention, U.S.FemaleFetusHumansInfantLactationPostpartum PeriodPractice Guidelines as TopicPregnancyPregnancy Complications, InfectiousUnited States

Pub Type(s)

Congress

Language

eng

PubMed ID

24457117

Citation

Meaney-Delman, Dana, et al. "Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women." Emerging Infectious Diseases, vol. 20, no. 2, 2014.
Meaney-Delman D, Zotti ME, Creanga AA, et al. Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Emerg Infect Dis. 2014;20(2).
Meaney-Delman, D., Zotti, M. E., Creanga, A. A., Misegades, L. K., Wako, E., Treadwell, T. A., Messonnier, N. E., & Jamieson, D. J. (2014). Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Emerging Infectious Diseases, 20(2). https://doi.org/10.3201/eid2002.130611
Meaney-Delman D, et al. Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women. Emerg Infect Dis. 2014;20(2) PubMed PMID: 24457117.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. AU - Meaney-Delman,Dana, AU - Zotti,Marianne E, AU - Creanga,Andreea A, AU - Misegades,Lara K, AU - Wako,Etobssie, AU - Treadwell,Tracee A, AU - Messonnier,Nancy E, AU - Jamieson,Denise J, AU - ,, PY - 2014/1/25/entrez PY - 2014/1/25/pubmed PY - 2014/9/3/medline KW - Bacillus anthracis KW - PEP KW - anthrax KW - antibacterial agents KW - antibiotics KW - antimicrobial drugs KW - antitoxins KW - bacteria KW - breast-feeding KW - lactation KW - postexposure prophylaxis KW - postpartum period KW - pregnancy KW - treatment KW - vaccination KW - vaccine KW - women JF - Emerging infectious diseases JO - Emerg Infect Dis VL - 20 IS - 2 N2 - In August 2012, the Centers for Disease Control and Prevention, in partnership with the Association of Maternal and Child Health Programs, convened a meeting of national subject matter experts to review key clinical elements of anthrax prevention and treatment for pregnant, postpartum, and lactating (P/PP/L) women. National experts in infectious disease, obstetrics, maternal fetal medicine, neonatology, pediatrics, and pharmacy attended the meeting, as did representatives from professional organizations and national, federal, state, and local agencies. The meeting addressed general principles of prevention and treatment for P/PP/L women, vaccines, antimicrobial prophylaxis and treatment, clinical considerations and critical care issues, antitoxin, delivery concerns, infection control measures, and communication. The purpose of this meeting summary is to provide updated clinical information to health care providers and public health professionals caring for P/PP/L women in the setting of a bioterrorist event involving anthrax. SN - 1080-6059 UR - https://www.unboundmedicine.com/medline/citation/24457117/full_citation DB - PRIME DP - Unbound Medicine ER -